Cubist Systematic Strategies, LLC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 167 filers reported holding REATA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 2.04 and the average weighting 0.5%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,222,728
-30.0%
21,800
-37.6%
0.02%
-21.1%
Q1 2023$3,177,290
+1042.7%
34,946
+377.5%
0.02%
+850.0%
Q4 2022$278,049
-64.8%
7,319
-76.7%
0.00%
-50.0%
Q3 2022$789,000
+34.0%
31,384
+61.9%
0.00%0.0%
Q2 2022$589,000
-36.2%
19,379
-31.3%
0.00%
-50.0%
Q1 2022$923,000
-19.7%
28,189
-35.4%
0.01%
-27.3%
Q4 2021$1,150,000
-64.0%
43,621
+37.5%
0.01%
-72.5%
Q3 2021$3,193,000
+12.7%
31,735
+58.5%
0.04%
+25.0%
Q2 2021$2,834,000
-19.5%
20,022
-43.3%
0.03%
-28.9%
Q1 2021$3,521,000
+120.6%
35,317
+173.6%
0.04%
+104.5%
Q4 2020$1,596,000
+65.4%
12,907
+30.3%
0.02%
+57.1%
Q3 2020$965,000
-55.8%
9,903
-29.3%
0.01%
-63.2%
Q2 2020$2,185,000
+1961.3%
14,002
+1805.0%
0.04%
+1166.7%
Q1 2020$106,000
-76.2%
735
-66.3%
0.00%
-62.5%
Q4 2019$446,000
+227.9%
2,183
+28.4%
0.01%
+166.7%
Q3 2019$136,000
+257.9%
1,700
+325.0%
0.00%
+200.0%
Q2 2019$38,000
-68.3%
400
-71.4%
0.00%
-75.0%
Q1 2019$120,000
-85.5%
1,400
-90.5%
0.00%
-89.7%
Q4 2018$825,000
+428.8%
14,711
+671.8%
0.04%
+333.3%
Q3 2018$156,000
+1.3%
1,906
-56.7%
0.01%
+12.5%
Q2 2018$154,0004,4000.01%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
CPMG Inc 2,896,901$291,457,00032.14%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 46,646$4,693,0005.31%
Ikarian Capital, LLC 471,400$47,423,0003.34%
Duquesne Family Office 695,033$69,927,0002.27%
Camber Capital Management LP 685,000$68,918,0002.12%
LBJ Family Wealth Advisors, Ltd. 30,359$3,054,0001.82%
MADDEN SECURITIES Corp 33,127$3,333,0001.80%
Biondo Investment Advisors, LLC 104,120$10,475,0001.80%
Tolleson Wealth Management, Inc. 60,750$6,112,0001.73%
Keel Point, LLC 97,074$9,767,0001.26%
View complete list of REATA PHARMACEUTICALS INC shareholders